AKT1 and diabetes mellitus: These data are consistent with previous research 76, such as platelet endothelial cell adhesion molecule (PECAM)-1 defects being key events for enhanced Akt/glycogen synthase kinase (GSK)-3β signaling in the diabetes mellitus (DM)-associated TME 77.